Invesco’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-132,375
Closed -$106K 3750
2020
Q2
$106K Sell
132,375
-15,890
-11% -$13.4K ﹤0.01% 3586
2020
Q1
$102K Buy
148,265
+111,092
+299% +$136K ﹤0.01% 3565
2019
Q4
$59K Sell
37,173
-2,451
-6% -$6.86K ﹤0.01% 3626
2019
Q3
$157K Sell
39,624
-1,548
-4% -$9K ﹤0.01% 3587
2019
Q2
$298K Sell
41,172
-1,434
-3% -$9.78K ﹤0.01% 3506
2019
Q1
$282K Buy
42,606
+35,543
+503% +$234K ﹤0.01% 3509
2018
Q4
$51K Buy
7,063
+1,207
+21% +$13.4K ﹤0.01% 3692
2018
Q3
$112K Buy
5,856
+280
+5% +$9.99K ﹤0.01% 3780
2018
Q2
$316K Sell
5,576
-2,269
-29% -$115K ﹤0.01% 3579
2018
Q1
$332K Buy
7,845
+2,866
+58% +$123K ﹤0.01% 3472
2017
Q4
$266K Buy
4,979
+27
+0.5% +$1.43K ﹤0.01% 3477
2017
Q3
$221K Buy
4,952
+226
+5% +$10.3K ﹤0.01% 3531
2017
Q2
$230K Buy
4,726
+1,342
+40% +$79K ﹤0.01% 3557
2017
Q1
$245K Buy
+3,384
New +$224K ﹤0.01% 3556
2015
Q3
Sell
-514
Closed -$79K 4144
2015
Q2
$79K Buy
+514
New +$84.8K ﹤0.01% 3908
2014
Q2
Sell
-34,411
Closed -$4.43M 4107
2014
Q1
$4.43M Sell
34,411
-44,190
-56% -$6.87M ﹤0.01% 2022
2013
Q4
$13.7M Buy
78,601
+4,533
+6% +$779K 0.01% 1372
2013
Q3
$12M Buy
74,068
+1,923
+3% +$303K 0.01% 1380
2013
Q2
$9.58M Buy
+72,145
New +$10.2M ﹤0.01% 1458

Other funds holding ELGX

Invesco's ELGX Position: Q3 2020 in Review

Invesco sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 132,375 shares — an estimated $106K sold.

Invesco first reported a position in ELGX in Q2 2013 and held it in 19 quarters. The position peaked at $13.7M in Q4 2013. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • Invesco reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • Invesco sold 132,375 Endologix Inc shares in Q3 2020, an estimated $106K.
  • Invesco first reported a position in Endologix Inc in Q2 2013 and held it in 19 quarters.
  • Invesco's Endologix Inc position peaked at $13.7M in Q4 2013.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Invesco's 13F filing for Q3 2020, filed 16 Nov 2020.